← All stocks

ArriVent BioPharma, Inc.

AVBP Net buying

CIK 0001868279 #2270 in the set updated 18 Sep 2026

Bought (120 mo)

$34.00M

out of their own pocket, the only kind of buying there is

Sold (120 mo)

$12.98M

$0.00 on a plan · $0.00 straight out of an exercise

Sold at will

$12.98M

1 of 1 sales

Net

+$21.02M

+$21.02M against sales at will

By person

5 insiders · 15 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

GORDON CARL L

Director

$8.00M (2)

—

+$8.00M

1,513,664

3.07%

$35.37M

—

HEALY JAMES

Director

$8.00M (1)

—

+$8.00M

1,696,752

3.44%

$39.65M

—

ORBIMED ADVISORS LLC entity

Director

$8.00M (2)

—

+$8.00M

1,513,664

3.07%

$35.37M

—

HILLHOUSE INVESTMENT MANAGEMENT, LTD. entity

10% owner

$10.00M (1)

$12.98M (1)

−$2.98M

3,929,117

7.97%

$91.82M

—

LaChapelle Robin

Chief Operating Officer

—

135,736

0.2753%

$3.17M

+39.9%

Individual transactions

Insider

Date

Role

Action

Price

Amount

HILLHOUSE INVESTMENT MANAGEMENT, LTD.

10 Dec 2025

10% owner

Sell indirect

555,555

$23.37

$12.98M

Show all 15 transactions →

What was left out

Form 4 filings counted 30

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 3

Sales on a Rule 10b5-1 plan 0

Sales straight out of an exercise 0

Sales at will 1

Transactions with no price 0

Shares from compensation/vesting 10,385,912

History held since 29 Jan 2024